C4 Therapeutics Inc (CCCC)
6.74
+0.31
(+4.82%)
USD |
NASDAQ |
May 03, 16:00
6.91
+0.17
(+2.52%)
After-Hours: 20:00
C4 Therapeutics 1 Year Total Returns (Daily): 114.6% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 114.6% |
May 02, 2024 | 106.8% |
May 01, 2024 | 101.9% |
April 30, 2024 | 108.6% |
April 29, 2024 | 109.3% |
April 26, 2024 | 102.3% |
April 25, 2024 | 104.6% |
April 24, 2024 | 105.4% |
April 23, 2024 | 109.7% |
April 22, 2024 | 108.5% |
April 19, 2024 | 104.3% |
April 18, 2024 | 117.3% |
April 17, 2024 | 99.71% |
April 16, 2024 | 103.9% |
April 15, 2024 | 104.8% |
April 12, 2024 | 137.5% |
April 11, 2024 | 139.3% |
April 10, 2024 | 147.4% |
April 09, 2024 | 141.5% |
April 08, 2024 | 132.1% |
April 05, 2024 | 147.4% |
April 04, 2024 | 149.0% |
April 03, 2024 | 146.9% |
April 02, 2024 | 144.6% |
April 01, 2024 | 158.0% |
Date | Value |
---|---|
March 28, 2024 | 145.3% |
March 27, 2024 | 132.7% |
March 26, 2024 | 124.3% |
March 25, 2024 | 131.9% |
March 22, 2024 | 127.7% |
March 21, 2024 | 118.8% |
March 20, 2024 | 120.9% |
March 19, 2024 | 121.1% |
March 18, 2024 | 108.4% |
March 15, 2024 | 107.2% |
March 14, 2024 | 118.6% |
March 13, 2024 | 141.7% |
March 12, 2024 | 145.7% |
March 11, 2024 | 142.7% |
March 08, 2024 | 124.0% |
March 07, 2024 | 118.1% |
March 06, 2024 | 122.5% |
March 05, 2024 | 103.9% |
March 04, 2024 | 107.4% |
March 01, 2024 | 117.8% |
February 29, 2024 | 108.3% |
February 28, 2024 | 107.8% |
February 27, 2024 | 82.58% |
February 26, 2024 | 78.42% |
February 23, 2024 | 49.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.28%
Minimum
Apr 04 2023
158.0%
Maximum
Apr 01 2024
-39.48%
Average
-68.93%
Median
1 Year Total Returns (Daily) Benchmarks
Exact Sciences Corp | -2.54% |
Alector Inc | -17.84% |
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |